2018
$300M
from 11 investors over 11 rounds
Tessera Therapeutics raised $300M on April 19, 2022
Investors: Longevity Vision Fund, ARTIS Ventures, Flagship Ventures, SoftBank Investment Advisers, March Capital and T. Rowe Price
Tessera Therapeutics raised $230M on January 12, 2021
Investors: Longevity Vision Fund, Alaska Permanent Fund Corporation, Qatar Investment Authority, SoftBank Investment Advisers and Flagship Ventures